N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain

Molecular Brain Research

Volumn 122, Issue 1, 2004, Pages 71-78

  Lu, Zi Hua ^a   Chakraborty, Goutam ^a   Ledeen, Robert W ^a   Yahya, Daniel ^a   Wu, Gusheng ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Acetyl CoA L aspartate N acetyltransferase (NAA synthase); ANAT; Brain microsomes and mitochondria; Dithiothreitol; DTT; Endoplasmic reticulum; Enzyme property; ER; INT; Multiple sclerosis; Myelin lipid synthesis; N Acetylaspartate; N Acetylaspartate synthase

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; ACETYL COENZYME A SYNTHETASE; BRAIN ENZYME; DETERGENT; HYDROLASE; N ACETYLASPARTIC ACID SYNTHASE; SODIUM DIHYDROGEN PHOSPHATE; SYNTHETASE; TYLOXAPOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BODY REGIONS; BRAIN CELL; BRAIN MICROSOME; BRAIN MITOCHONDRION; CELL COMPARTMENTALIZATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; THIN LAYER CHROMATOGRAPHY;

EID: 1342285559     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.12.002     Document Type: Article

References (63)

1. Alberghina M.M., Viola M., Giuffrida A.M. Transfer of axonally transported phospholipids into myelin isolated from rabbit optic pathway. Neurochem. Res. 7:1982;139-149.
2. Anandatheerthavarada H.K., Biswas G., Mullick J., Sepuri N.B.V., Otvos L., Pain D., Avadhani N.G. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at Ser128. EMBO J. 18:1999;5494-5504.
3. Anderson M.F., Sims N.R. Improved recovery of highly enriched mitochondrial fractions from small brain tissue samples. Brain Res. Protoc. 5:2000;95-101.
4. Ando S., Tanaka Y., Toyoda Y., Kon K. Turnover of myelin lipids in aging brain. Neurochem. Res. 28:2003;5-13.
5. Ardies C.M., Lasker J.M., Bloswick B.P., Lieber C.S. Purification of NADPH:cytochrome c (cytochrome P-450) reductase from hamster liver microsomes by detergent extraction and affinity chromatography. Anal. Biochem. 162:1987;39-46.
6. Arnold D.L., Matthews P.M., Francis G., Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14:1990;154-159.
7. Baslow M.H. Functions of N-acetyl-L-aspartate and N-acetyl-L- aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J. Neurochem. 75:2000;453-459.
8. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28:2003;941-953.
9. Baslow M.H., Resnick T.R. Canavan disease: analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J. Mol. Neurosci. 9:1997;109-126.
10. Baslow M.H., Suckow R.F., Sapirstein V., Hungund B.L. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J. Mol. Neurosci. 13:1999;47-53.
11. Bates T.E., Strangward M., Keelan J., Davey G.P., Munro P.M.G., Clark J.B. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. NeuroReport. 7:1996;1397-1400.
12. Bhakoo K.K., Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J. Neurochem. 74:2000;254-262.
13. Bhakoo K.K., Craig T.J., Styles P. Developmental and regional distribution of aspartoacylase in rat brain tissue. J. Neurochem. 79:2001;211-220.
14. Birken D.L., Oldendorf W.H. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. 13:1989;23-31.
15. Bjartmar C., Battistuta J., Terada N., Dupree E., Trapp B.D. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann. Neurol. 51:2002;51-58.
16. Block W., Traber F., Flacke S., Jessen F., Pohl C., Schild H. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids. 23:2002;317-323.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
18. Burri R., Steffen C., Herschkowitz N. N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci. 13:1991;403-411.
19. Chakraborty G., Ledeen R. Fatty acid synthesizing enzymes intrinsic to myelin. Mol. Brain Res. 112:2003;46-52.
20. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 78:2001;736-745.
21. Clark J.B. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20:1998;271-276.
22. D'Adamo A.F., Yatsu F.M. Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids. J. Neurochem. 13:1966;961-963.
23. D'Adamo A.F., Smith J.C., Woiler C. The occurrence of N-acetylaspartate amidohyddrolase (aminoacylase II) in the developing rat. J. Neurochem. 20:1973;1275-1278.
24. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., Miller D.H., McDonald W.I. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
25. Droz B., Di Giamberardino L., Koenig H.L., Boyenval J., Hassig R. Axon-myelin transfer of phospholipid components in the course of their axonal-transport as visualized by radioautography. Brain Res. 155:1978;347-353.
26. Filippi M., Bozzali M., Rovaris R., Gonen O., Kesavadas C., Ghezzi A., Martinelli V., Grossman R.I., Scotti G., Comi G., Falini A. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain. 126:2003;433-437.
27. 1H NMR spectroscopy and high performance liquid chromatography. Neurochem. Res. 21:1996;1065-1074.
28. Gordon D.M., Shi Q., Dancis A., Pain D. Maturation of frataxin within mammalian and yeast mitochondria: one-step processing by matrix processing peptidase. Hum. Mol. Genet. 8:1999;2255-2262.
29. Kaul R., Casanova J., Johnson A.B., Tang P., Matalon R. Purification, characterization and localization of aspartoacylase from bovine brain. J. Neurochem. 56:1991;129-135.
30. Kirmani B.F., Jacobowitz D.M., Namboodiri M.A.A. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Dev. Brain Res. 140:2003;105-115.
31. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain. 125:2002;2202-2212.
32. Ledeen R.W. Enzymes and receptors of myelin. Martenson R.E. Myelin: Biology and Chemistry. 1992;531-570 CRC Press, Boca Raton, FL.
33. Ledeen R.W., Haley J.E. Axon-myelin transfer of glycerol-labeled lipids and inorganic phosphate during axonal transport. Brain Res. 269:1983;267-275.
34. Ledeen R.W., Golly F., Haley J.E. Axon-myelin transfer of phospholipids and phospholipid precursors. Labeling of myelin phosphoinositides through axonal transport. Mol. Neurobiol. 6:1992;179-190.
35. R.W. Ledeen, Z.-H. Lu, G. Chakraborty, D. Yahya, A. Singh, G. Wu, Bimodal targeting of N-acetylaspartate synthase in CNS neurons, J. Neurochem. (Abstr.) (in press).
36. Lees M., Paxman S. Modification of the Lowry procedure for analysis of proteolipid protein. Anal. Biochem. 47:1972;184-192.
37. Lees M., Sapirstein V.S. Myelin-associated enzymes. Lajtha A. Handbook of Neurochemistry. Enzymes of the Nervous System. vol. 4:1983;435-460 Plenum, New York, NY.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
39. Madhavarao C.N., Hammer J.A., Quarles R.H., Namboodiri M.A.A. A radiometric assay for aspartoacylase activity in cultured oligodendrocytes. Anal. Biochem. 308:2002;314-319.
40. Martin E., Capone A., Schneider J., Hennig J., Thiel T. Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann. Neurol. 49:2001;518-521.
41. Matalon R., Michals K., Sebasta D., Deanching M., Gashkoff P., Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29:1988;463-471.
42. Matalon R., Michals K., Kaul R. Canavan disease: from spongy degeneration to molecular analysis. J. Pediatr. 127:1995;511-517.
43. Mehta V., Namboodiri M.A.A. N-acetylaspartate as an acetyl source in the nervous system. Mol. Brain Res. 31:1995;151-157.
44. Moffett J.R., Namboodiri M.A.A. Differential distribution of N-acetyl-aspartylglutamic acid and N-acetylaspartate immunoreactivities in rat brain. J. Neurocytol. 24:1995;409-433.
45. Moffett J.R., Namboodiri M.A.A., Cangro C., Neale J.H. Immunochemical localization of N-acetylaspartate in rat brain. NeuroReport. 2:1991;131-134.
46. 13C]glucose infusion. J. Neurochem. 44:2001;347-350.
47. Neale J.H., Bzdega T., Wroblewska B. N-acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75:2000;443-452.
48. Norton W.T., Cammer W. Isolation and characterization of myelin. Morell P. Myelin. 1984;147-195 Plenum, New York, NY.
49. Patel T.B., Clark J.B. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184:1979;539-546.
50. Robin M.-A., Anandatheerthavarada H.K., Biswas G., Sepuri N.B.V., Gordon D.M., Pain D., Avadhani N.G. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J. Biol. Chem. 277:2002;40583-40593.
51. Sepuri N.B.V., Gordon D.M., Pain D. A GTP-dependent "push" is generally required for efficient protein translocation across the mitochondrial inner membrane into the matrix. J. Biol. Chem. 273:1998;20941-20950.
52. Shiao Y.J., Lupo G., Vance J.E. Evidence that phosphatidylserine is imported into mitochondria via a mitochondria-associated membrane and that the majority of mitochondrial phosphatidylethanolamine is derived from decarboxylation of phosphatidylserine. J. Biol. Chem. 270:1995;11190-11198.
53. Simmons M.D., Frondoza C.G., Coyle J.T. Immunocytochemical localization of N-acetylaspartate with monoclonal antibodies. Neuroscience. 45:1991;37-45.
54. Storrie B., Madden E.A. Isolation of subcellular organelles. Methods Enzymol. 182:1990;203-225.
55. Tallan H.H. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 224:1957;41-45.
56. Tallan H.H., Moore S., Stein W.H. N-Acetyl-L-aspartic acid in brain. J. Biol. Chem. 219:1956;257-264.
57. Taylor D.L., Davies S.E.C., Obrenovitch T.P., Doheny M.H., Patsalos P.N., Clark J.B., Symon L. Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J. Neurochem. 65:1995;275-281.
58. Toews A.D., Armstrong R., Ray R., Gould R.M., Morell P. Deposition and transfer of axonally transported phospholipids in rat sciatic nerve. J. Neurosci. 8:1988;593-601.
59. Truckenmiller M.E., Namboodiri M.A., Brownstein M.J., Neale J.H. N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem. 45:1985;1658-1662.
60. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46:1995;531-540.
61. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specific expression of N-acetyl-aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59:1992;55-61.
62. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13:1993;981-989.
63. van Walderveen M.A., Barkhof F., Pouwels P.J.W., Schijndel R.A., Polman C.H., Castelijns J.A. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann. Neurol. 46:1999;79-87.